- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Skin Cancer
Volume 2011 (2011), Article ID 423239, 8 pages
doi:10.1155/2011/423239
BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance
1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02114, USA
2Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA
Received 10 July 2011; Revised 27 September 2011; Accepted 28 September 2011
Academic Editor: S. Ugurel
Copyright © 2011 Ryan J. Sullivan and Keith T. Flaherty. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Ryan J. Sullivan and Keith T. Flaherty, “BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance,” Journal of Skin Cancer, vol. 2011, Article ID 423239, 8 pages, 2011. doi:10.1155/2011/423239